287 related articles for article (PubMed ID: 22886028)
1. Cognitive enhancers (nootropics). Part 1: drugs interacting with receptors.
Froestl W; Muhs A; Pfeifer A
J Alzheimers Dis; 2012; 32(4):793-887. PubMed ID: 22886028
[TBL] [Abstract][Full Text] [Related]
2. Cognitive enhancers (nootropics). Part 2: drugs interacting with enzymes.
Froestl W; Muhs A; Pfeifer A
J Alzheimers Dis; 2013; 33(3):547-658. PubMed ID: 23042218
[TBL] [Abstract][Full Text] [Related]
3. Cognitive enhancers (nootropics). Part 3: drugs interacting with targets other than receptors or enzymes. disease-modifying drugs.
Froestl W; Pfeifer A; Muhs A
J Alzheimers Dis; 2013; 34(1):1-114. PubMed ID: 23186990
[TBL] [Abstract][Full Text] [Related]
4. Cognitive enhancers (Nootropics). Part 3: drugs interacting with targets other than receptors or enzymes. Disease-modifying drugs. Update 2014.
Froestl W; Pfeifer A; Muhs A
J Alzheimers Dis; 2014; 42(4):1079-149. PubMed ID: 25061058
[TBL] [Abstract][Full Text] [Related]
5. Cognitive enhancers (Nootropics). Part 1: drugs interacting with receptors. Update 2014.
Froestl W; Muhs A; Pfeifer A
J Alzheimers Dis; 2014; 41(4):961-1019. PubMed ID: 24898652
[TBL] [Abstract][Full Text] [Related]
6. Cognitive enhancers (nootropics). Part 2: drugs interacting with enzymes. Update 2014.
Froestl W; Muhs A; Pfeifer A
J Alzheimers Dis; 2014; 42(1):1-68. PubMed ID: 24903780
[TBL] [Abstract][Full Text] [Related]
7. Design and study of piracetam-like nootropics, controversial members of the problematic class of cognition-enhancing drugs.
Gualtieri F; Manetti D; Romanelli MN; Ghelardini C
Curr Pharm Des; 2002; 8(2):125-38. PubMed ID: 11812254
[TBL] [Abstract][Full Text] [Related]
8. Drug targets for cognitive enhancement in neuropsychiatric disorders.
Wallace TL; Ballard TM; Pouzet B; Riedel WJ; Wettstein JG
Pharmacol Biochem Behav; 2011 Aug; 99(2):130-45. PubMed ID: 21463652
[TBL] [Abstract][Full Text] [Related]
9. On the trail of a cognitive enhancer for the treatment of schizophrenia.
Stip E; Chouinard S; Boulay LJ
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):219-32. PubMed ID: 15694228
[TBL] [Abstract][Full Text] [Related]
10. Emerging cognitive enhancing drugs.
Buccafusco JJ
Expert Opin Emerg Drugs; 2009 Dec; 14(4):577-89. PubMed ID: 19772371
[TBL] [Abstract][Full Text] [Related]
11. Cognitive enhancement: promises and perils.
Hyman SE
Neuron; 2011 Feb; 69(4):595-8. PubMed ID: 21338872
[TBL] [Abstract][Full Text] [Related]
12. Putative cognitive enhancers in preclinical models related to schizophrenia: the search for an elusive target.
Barak S; Weiner I
Pharmacol Biochem Behav; 2011 Aug; 99(2):164-89. PubMed ID: 21420999
[TBL] [Abstract][Full Text] [Related]
13. [Cognitive enhancement effect of piracetam in patients with mild cognitive impairment and dementia].
Tariska P; Paksy A
Orv Hetil; 2000 May; 141(22):1189-93. PubMed ID: 10853348
[TBL] [Abstract][Full Text] [Related]
14. [Nootropes (cognition enhancers) and neuroprotectors].
Vornin TA; Seredenin SB
Eksp Klin Farmakol; 2007; 70(4):44-58. PubMed ID: 18078043
[TBL] [Abstract][Full Text] [Related]
15. Cognition enhancers between treating and doping the mind.
Lanni C; Lenzken SC; Pascale A; Del Vecchio I; Racchi M; Pistoia F; Govoni S
Pharmacol Res; 2008 Mar; 57(3):196-213. PubMed ID: 18353672
[TBL] [Abstract][Full Text] [Related]
16. A cog in cognition: how the alpha 7 nicotinic acetylcholine receptor is geared towards improving cognitive deficits.
Leiser SC; Bowlby MR; Comery TA; Dunlop J
Pharmacol Ther; 2009 Jun; 122(3):302-11. PubMed ID: 19351547
[TBL] [Abstract][Full Text] [Related]
17. Piracetam: novelty in a unique mode of action.
Müller WE; Eckert GP; Eckert A
Pharmacopsychiatry; 1999 Mar; 32 Suppl 1():2-9. PubMed ID: 10338102
[TBL] [Abstract][Full Text] [Related]
18. Cognitive enhancers: molecules, mechanisms and minds.
Frenguelli BG
Neuropharmacology; 2013 Jan; 64():1. PubMed ID: 22985720
[No Abstract] [Full Text] [Related]
19. The families of cognition enhancers.
Fröstl W; Maître L
Pharmacopsychiatry; 1989 Oct; 22 Suppl 2():54-100. PubMed ID: 2690152
[TBL] [Abstract][Full Text] [Related]
20. AMPA receptor potentiators as cognitive enhancers.
O'Neill MJ; Dix S
IDrugs; 2007 Mar; 10(3):185-92. PubMed ID: 17351873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
